Takahashi I, Iwasawa Y, Hayama T,
Nishimura S, Morishima H (2001) Structure-
based generation of a new class of potent Cdk4
inhibitors: new de novo design strategy and
library design. J Med Chem 44
(26):4615–4627- Grzybowski BA, Ishchenko AV, Kim CY,
Topalov G, Chapman R, Christianson DW,
Whitesides GM, Shakhnovich EI (2002) Com-
binatorial computational method gives new
picomolar ligands for a known enzyme. Proc
Natl Acad Sci U S A 99(3):1270–1273.
https://doi.org/10.1073/pnas.032673399 - Schneider G (2002) Trends in virtual combina-
torial library design. Curr Med Chem
9:2095–2101 - Dobson CM (2004) Chemical space and biol-
ogy. Nature 432:824–828 - Lipinski C, Hopkins A (2004) Navigating
chemical space for biology and medicine.
Nature 432:855–861 - Richardson JS, Richardson DC (1989) The de
novo design of protein structures. Trends Bio-
chem Sci 14:304–309 - Richardson JS (1992) Looking at proteins:
representations, folding, packing, and design.
Biophys J 63:1185–1209 - Bohm HJ, Flohr A, Stahl M (2004) Scaffold
hopping. Drug Discov Today Technol 1
(3):217–224. https://doi.org/10.1016/j.
ddtec.2004.10.009 - Renner S, Schneider G (2006) Scaffold-
hopping potential of ligand-based similarity
concepts. ChemMedChem 1(2):181–185.
https://doi.org/10.1002/cmdc.200500005 - Mauser H, Guba W (2008) Recent develop-
ments in de novo design and scaffold hopping.
Curr Opin Drug Discov Devel 11(3):365–374 - Langdon SR, Ertl P, Brown N (2010) Bioisos-
teric replacement and scaffold hopping in lead
generation and optimization. Mol Inform 29
(5):366–385.https://doi.org/10.1002/minf.
201000019 - Loving K, Alberts I, Sherman W (2010)
Computational approaches for fragment-
based and de novo design. Curr Top Med
Chem 10(1):14–32 - Schneider G, Fechner U (2005) Computer-
based de novo design of drug-like molecules.
Nat Rev Drug Discov 4(8):649–663 - Katiyar SP, Bakkiyaraj D, Karutha Pandian S
(2011) Role of aromatic stack pairing at the
catalytic site of gelonin protein. Biochem Bio-
phys Res Commun 410(1):75–80.https://doi.
org/10.1016/j.bbrc.2011.05.107 - Shacham S, Marantz Y, Bar-Haim S, Kalid O,
Warshaviak D, Avisar N, Inbal B, Heifetz A,
Fichman M, Topf M, Naor Z, Noiman S,
Becker OM (2004) PREDICT modeling and
in-silico screening for G-protein coupled
receptors. Proteins 57(1):51–86.https://doi.
org/10.1002/prot.20195- Hillisch A, Pineda LF, Hilgenfeld R (2004)
Utility of homology models in the drug discov-
ery process. Drug Discov Today 9
(15):659–669. https://doi.org/10.1016/
S1359-6446(04)03196-4 - Dhanjal JK, Sreenidhi AK, Bafna K, Katiyar SP,
Goyal S, Grover A, Sundar D (2015) Compu-
tational structure-based de novo design of
hypothetical inhibitors against the anti-
inflammatory target COX-2. PLoS One 10
(8):e0134691.https://doi.org/10.1371/jour
nal.pone.0134691 - Fechner U, Schneider G (2006) Flux (1): a
virtual synthesis scheme for fragment-based
de novo design. J Chem Inf Model 46
(2):699–707. https://doi.org/10.1021/
ci0503560 - Lloyd DG, Buenemann CL, Todorov NP,
Manallack DT, Dean PM (2004) Scaffold hop-
ping in de novo design. Ligand generation in
the absence of receptor information. J Med
Chem 47(3):493–496. https://doi.org/10.
1021/jm034222u - Pasha FA, Muddassar M, Beg Y, Cho SJ (2008)
DFT-based de novo QSAR of phenoloxidase
inhibitors. Chem Biol Drug Des 71
(5):483–493. https://doi.org/10.1111/j.
1747-0285.2008.00651.x - Goodford PJ (1985) A computational proce-
dure for determining energetically favorable
binding sites on biologically important macro-
molecules. J Med Chem 28(7):849–857 - Miranker A, Karplus M (1991) Functionality
maps of binding sites: a multiple copy simulta-
neous search method. Proteins 11(1):29–34.
https://doi.org/10.1002/prot.340110104 - Bohm HJ (1992) LUDI: rule-based automatic
design of new substituents for enzyme inhibi-
tor leads. J Comput Aided Mol Des 6
(6):593–606 - Mills JE, Dean PM (1996) Three-dimensional
hydrogen-bond geometry and probability
information from a crystal survey. J Comput
Aided Mol Des 10(6):607–622 - Pearlman DA (1999) Free energy grids: a prac-
tical qualitative application of free energy per-
turbation to ligand design using the OWFEG
method. J Med Chem 42(21):4313–4324 - Halgren TA (2009) Identifying and character-
izing binding sites and assessing druggability. J
Chem Inf Model 49(2):377–389.https://doi.
org/10.1021/ci800324m
142 Shashank P. Katiyar et al.